HPV Vaccine In-Waiting Glaxo, still struggling to overcome the Avandia diabetes pill controversy and subsequent lost revenue, has been dealt another blow by the FDA. The agency has issued a “complete response letter” to Glaxo for its Cervarix vaccine. It is unclear whether the … [Read more...] about Glaxo’s Cervarix Not Feeling the FDA Love
Cervarix
Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market
Glaxo Still Chasing FDA Approval For Cervarix The FDA’s approval for the ‘other’ HPV-vaccine, Cervarix is still delayed. GlaxoSmithKline, the world's second-largest drugmaker, requested a 'priority' review, potentially prompting an approval decision and sale of the Cervarix … [Read more...] about Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market